Key Metrics of MannKind Corporation
Revenue$199M▲ 99.4% YoYFY 2023
Operating income$8.7M▲ 113.5% YoY
Net profit−$11.9M▲ 86.3% YoY
Shareholders' equity−$246M
Market cap$1.1BMNKD · $3.43
Competitors10identified
About MannKind Corporation
Sectors
Company details
- Website
- mannkindcorp.com
- Founded
- 2004
- Listed
- Nasdaq: MNKD (since 2004)
Operational Areas of MannKind Corporation
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameMannKind Corporation
TickerMNKD
ExchangeNasdaq
CountryUnited States
SEC CIK0000899460
Listed since2004
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttps://mannkindcorp.com
US market & SEC filings
MNKD · Nasdaq · SEC CIK 0000899460
Last price · 30 Oct 2026
$3.43
+4.26%
Market cap$1.1B
P/E—On FY 2023 diluted EPS
Volume3,078,560
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 2004
MNKD share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeDanbury
GSTIN—
Email—
Websitehttps://mannkindcorp.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of MannKind Corporation
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | twistbioscience.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | 10xgenomics.com | 2019 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
biotechnology
Filings
No filings on record yet.